HEMOFLOW Cloud (HEMOFLOW) for non-invasive haemodynamic diagnostics (Q77962): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:art:25 Commission Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of this project is to carry out (b) industrial, development and pre-implementation on innovative diagnostic technology in the form of the HEMOFLOW cloud platfo...) |
||
| Property / summary | |||
Reference_reference_programme_aids:SA.41471 (2015/X) _public:art:25 Commission Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of this project is to carry out (b) industrial, development and pre-implementation on innovative diagnostic technology in the form of the HEMOFLOW cloud platform, for a non-invasive, haemodynamic assessment based on the licensed patenting of the originator technology and SIL-FFR (in Silicco functional Flow Reserve) Applicant.The implementation of the project will allow the implementation of an extended and non-invasive diagnosis of ischaemic heart disease, including both an anatomical/structural assessment and a functional assessment of the blood flow in the coronary artery correlated with the assessment of the degree of perfusion of the microkardium based on the following clinical data:medical history, CCTA imaging data and 1-3 min continuous blood pressure signal measurement (CNBP — Contininous Intinous Block Pressure).HEMOFLOW platform mobilised in the SaS modelSoftware as a Service) will supply inspector tools.Based on Comp Model.In Silico (CFD) using numerators of liquids (CFD — Computing Fluid Dynamics).They will give the user (s) the option to carry out a stand-alone structural and functional assessment of virtual 3D coronary artery arterial reconstruction (virtual measurement of the sub-reserve of coronary artery disease — FFR) correlated with 3D visualisation of a mitokardium (virtual 3D perfusion maps).According to the current state of the knowledge, there is no product available on the market in Silco, together, these two types of diagnostic information improved by the correlation between flow in coronary arteries and the degree of myocardial infarction.This solution, at the time of the confirmation of its effectiveness in b (English) | |||
| Property / summary: Reference_reference_programme_aids:SA.41471 (2015/X) _public:art:25 Commission Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of this project is to carry out (b) industrial, development and pre-implementation on innovative diagnostic technology in the form of the HEMOFLOW cloud platform, for a non-invasive, haemodynamic assessment based on the licensed patenting of the originator technology and SIL-FFR (in Silicco functional Flow Reserve) Applicant.The implementation of the project will allow the implementation of an extended and non-invasive diagnosis of ischaemic heart disease, including both an anatomical/structural assessment and a functional assessment of the blood flow in the coronary artery correlated with the assessment of the degree of perfusion of the microkardium based on the following clinical data:medical history, CCTA imaging data and 1-3 min continuous blood pressure signal measurement (CNBP — Contininous Intinous Block Pressure).HEMOFLOW platform mobilised in the SaS modelSoftware as a Service) will supply inspector tools.Based on Comp Model.In Silico (CFD) using numerators of liquids (CFD — Computing Fluid Dynamics).They will give the user (s) the option to carry out a stand-alone structural and functional assessment of virtual 3D coronary artery arterial reconstruction (virtual measurement of the sub-reserve of coronary artery disease — FFR) correlated with 3D visualisation of a mitokardium (virtual 3D perfusion maps).According to the current state of the knowledge, there is no product available on the market in Silco, together, these two types of diagnostic information improved by the correlation between flow in coronary arteries and the degree of myocardial infarction.This solution, at the time of the confirmation of its effectiveness in b (English) / rank | |||
Normal rank | |||
Revision as of 08:55, 4 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HEMOFLOW Cloud (HEMOFLOW) for non-invasive haemodynamic diagnostics |
Project in Poland financed by DG Regio |
Statements
12,953,985.55 zloty
0 references
19,417,540.5 zloty
0 references
66.71 percent
0 references
1 October 2019
0 references
30 April 2022
0 references
LIFE FLOW SP. Z O. O.
0 references
51°7'34.7"N, 16°58'41.5"E
0 references
Numer_referencyjny_programu_pomocowego: SA.41471(2015/X) Przeznaczenie_pomocy_publicznej: art: 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26.06.2014). Przedmiotem niniejszego Projektu jest przeprowadzenie b. przemysłowych, prac rozwojowych oraz przedwdrożeniowych nad innowacyjną technologią diagnostyczną w postaci platformy chmurowej HEMOFLOW, do nieinwazyjnej oceny hemodynamicznej bazującej na objętej procesem patentowania autorskiej technologii iSIL-FFR (in Silico Fractional Flow Reserve) Wnioskodawcy. Realizacja projektu umożliwi wykonanie rozszerzonej i nieinwazyjnej diagnostyki choroby niedokrwiennej serca obejmującej zarówno ocenę anatomiczną/strukturalną jak również ocenę czynnościową przepływu krwi w tętnicach wieńcowych skorelowaną z oceną stopnia perfuzji miokardium w oparciu o następujące dane kliniczne: wywiad lekarski, dane obrazowe z badania CCTA (Coronary Computed Tomography Angiography) oraz 1-3 min. ciągły pomiar sygnału fali ciśnienia krwi ( CNBP - Continous Noninvasive Blood Pressure). PLATFORMA HEMOFLOW, uruchamiana w modelu SaaS (ang. Software as a Service), będzie dostarczać narzędzi diagn. Bazujących na modelowaniu komp. (in Silico) z wykorzystaniem numerycznej mechaniki płynów (CFD – Computational Fluid Dynamics). Dadzą one użytkownikowi (lekarzowi) możliwość wykonania samodzielnej oceny strukturalnej i czynnościowej na wirtualnej 3D rekonstrukcji tętnic wieńcowych (wirtualny pomiar Cząstkowej Rezerwy Przepływu wieńcowego – FFR) skorelowanej z 3D wizualizacją miokardium (wirtualne 3D mapy stopnia perfuzji). Według aktualnego stanu wiedzy, nie istnieje na rynku produkt udostępniający in Silico łącznie te dwa rodzaje informacji diagnostycznej ulepszone o korelacje między przepływem w tętnicach wieńcowych a stopniem ukrwienia mięśnia sercowego. Rozwiązanie to, w momencie potwierdzenia jego skuteczności w b (Polish)
0 references
Reference_reference_programme_aids:SA.41471 (2015/X) _public:art:25 Commission Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of this project is to carry out (b) industrial, development and pre-implementation on innovative diagnostic technology in the form of the HEMOFLOW cloud platform, for a non-invasive, haemodynamic assessment based on the licensed patenting of the originator technology and SIL-FFR (in Silicco functional Flow Reserve) Applicant.The implementation of the project will allow the implementation of an extended and non-invasive diagnosis of ischaemic heart disease, including both an anatomical/structural assessment and a functional assessment of the blood flow in the coronary artery correlated with the assessment of the degree of perfusion of the microkardium based on the following clinical data:medical history, CCTA imaging data and 1-3 min continuous blood pressure signal measurement (CNBP — Contininous Intinous Block Pressure).HEMOFLOW platform mobilised in the SaS modelSoftware as a Service) will supply inspector tools.Based on Comp Model.In Silico (CFD) using numerators of liquids (CFD — Computing Fluid Dynamics).They will give the user (s) the option to carry out a stand-alone structural and functional assessment of virtual 3D coronary artery arterial reconstruction (virtual measurement of the sub-reserve of coronary artery disease — FFR) correlated with 3D visualisation of a mitokardium (virtual 3D perfusion maps).According to the current state of the knowledge, there is no product available on the market in Silco, together, these two types of diagnostic information improved by the correlation between flow in coronary arteries and the degree of myocardial infarction.This solution, at the time of the confirmation of its effectiveness in b (English)
0 references
Identifiers
POIR.01.01.01-00-0393/19
0 references